Similar articles

• Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.

  Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA. Cecilia D, et al. Virology. 2000 Jun 5;271(2):253-8. doi: 10.1006/viro.2000.0297. Virology. 2000. PMID: 10860879
• HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.

  Soulié C, Marcelin AG, Ghosn J, Amellal B, Assoumou L, Lambert S, Duvivier C, Costagliola D, Katlama C, Calvez V. Soulié C, et al. AIDS. 2007 Oct 18;21(16):2243-5. doi: 10.1097/QAD.0b013e3282f0e3d0. AIDS. 2007. PMID: 18090053
• The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

  Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G. Waters L, et al. Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660. Clin Infect Dis. 2008. PMID: 18419499
• HIV coreceptor phenotyping in the clinical setting.

  Low AJ, Swenson LC, Harrigan PR. Low AJ, et al. AIDS Rev. 2008 Jul-Sep;10(3):143-51. AIDS Rev. 2008. PMID: 18820716 Review.
• HIV type 1 tropism and inhibitors of viral entry: clinical implications.

  Weber J, Piontkivska H, Quiñones-Mateu ME. Weber J, et al. AIDS Rev. 2006 Apr-Jun;8(2):60-77. AIDS Rev. 2006. PMID: 16848274 Review.